Product details

  • ASCENIV™ is a liquid solution containing 10% IgG (100 mg/mL) for intravenous infusion1
  • The broad spectrum of neutralizing IgG antibodies against bacterial and viral pathogens and their toxins helps to avoid recurrent serious opportunistic infections
  • Purified, sterile, ready-to-use preparation
  • Clear to opalescent liquid (colorless to pale yellow)
  • Normal IgG subclass distribution
  • Formulated in water for injection containing 0.100 M-0.140 M sodium chloride, 0.20 M-0.29 M glycine, 0.15%-0.25% polysorbate 80, and pH 4.0-4.6. Contains no sucrose
  • Contains ≤200 μg/mL of immunoglobulin A
  • Mean half-life of ASCENIV™:
     – 28.5 ± 4.4 days for patients on a 3-week dosing regimen
     – 39.7 ± 11.6 days for patients on a 4-week dosing regimen

The only IGIV available that is manufactured using ADMA Biologics’ patented methodologies for donor screening and plasma pooling.*

Size of vial not to scale

Available in a single-use,non-latex, tamper-evident 5 g/50 mL vial.

Storage and Handling1

  • Refrigerate between 2° to 8°C (36° to 46°F)
  • Do not freeze or heat. Do not use any solutions that have been frozen or heated
  • Do not use after expiration date

*ADMA BIOLOGICS PATENTS ISSUED 9,107,906 - 9,714,283 - 9,815,886.